SONVY:OTO-Sonova Holding AG ADR (USD)

COMMON STOCK | Medical Devices | OTC Pink

Last Closing

USD 65.93

Change

+2.67 (+4.22)%

Market Cap

USD 8.46B

Volume

8.49K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Sonova Holding AG along with its subsidiaries is engaged in the design, development, manufacture, distribution and service of technologically advanced hearing systems for adults and children with hearing impairment.

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-15 )

Largest Industry Peers for Medical Devices

Symbol Name Price(Change) Market Cap
SEMHF Siemens Healthineers AG

N/A

USD 63.76B
SMMNY Siemens Healthineers AG ADR

-0.42 (-1.58%)

USD 62.17B
RYLPF Koninklijke Philips N.V

N/A

USD 29.83B
SONVF Sonova Holding AG

N/A

USD 22.04B
SNWV SANUWAVE Health Inc

-1.50 (-7.89%)

USD 20.67B
SNNUF Smith & Nephew plc

+0.01 (+0.03%)

USD 12.78B
WILLF Demant A/S

N/A

USD 8.72B
GNGBF Getinge AB

N/A

USD 5.12B
AMBFF Ambu A/S

N/A

USD 4.94B
AMBBY Ambu A/S

N/A

USD 4.94B

ETFs Containing SONVY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Medical Devices) Market Performance vs. Exchange (OTC Pink)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 0.93% 61% D- 51% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 0.93% 59% D- 49% F
Trailing 12 Months  
Capital Gain 19.37% 80% B- 76% C+
Dividend Return 1.85% 82% B 24% F
Total Return 21.23% 79% B- 75% C
Trailing 5 Years  
Capital Gain 62.51% 84% B 82% B
Dividend Return 7.34% 64% D 23% F
Total Return 69.86% 84% B 81% B-
Average Annual (5 Year Horizon)  
Capital Gain 11.29% 60% D- 58% F
Dividend Return 12.38% 60% D- 55% F
Total Return 1.09% 62% D 26% F
Risk Return Profile  
Volatility (Standard Deviation) 33.84% 81% B- 66% D+
Risk Adjusted Return 36.59% 83% B 74% C
Market Capitalization 8.46B 98% N/A 93% A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior capital utilization

The company management has delivered better return on invested capital in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Earnings Growth

This stock has shown top quartile earnings growth in the previous 5 years compared to its sector.

High Gross Profit to Asset Ratio

This stock is in the top quartile compared to its peers on Gross Profit to Asset Ratio. This is a popular measure among value investors for showing superior returns in the long run.

What to not like:
Highly leveraged

The company is in the bottom half compared to its sector peers on debt to equity and is highly leveraged. However, do check the news and look at its sector and management statements. Sometimes this is high because the company is trying to grow aggressively.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Revenue Growth

This stock has shown below median revenue growth in the previous 5 years compared to its sector

Low Dividend Growth

This stock has shown below median dividend growth in the previous 5 years compared to its sector.